封面
市场调查报告书
商品编码
1987022

DNA资料储存系统市场分析与预测(至2035年):类型、产品类型、服务、技术、组件、应用、流程、部署模式、最终用户、解决方案

DNA Data Storage Systems Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, Deployment, End User, Solutions

出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球DNA资料储存系统市场预计将从2025年的12亿美元成长到2035年的58亿美元,复合年增长率(CAGR)为16.5%。这一增长主要受数据生成量不断增加、DNA合成和定序技术进步以及对长期高密度储存解决方案的需求所驱动。 DNA资料储存系统市场的特点是发展迅速,但仍处于早期发展阶段。主要细分市场包括基于合成的储存解决方案(约占市场份额的60%)、基于定序的搜寻系统(约占30%)以及其他相关技术(约占10%)。其主要应用是归檔资料存储,但医疗和生命科学领域对长期资料保存的需求也日益增长。该市场集中度适中,由少数几家主要企业主导,但随着技术的进步,新参与企业也不断增加。由于该市场仍处于商业化初期,目前销售量资讯有限,其应用主要集中在研究机构和先导计画中。

竞争格局的特点是既有全球科技巨头,也有专注于特定区域的专业公司。创新水准很高,这主要得益于合成生物学和奈米技术的进步。併购十分活跃,大型公司透过收购Start-Ups来增强自身的技术实力。科技公司与研究机构之间的策略合作也十分普遍,旨在加速DNA资料储存解决方案的开发和商业化。

市场区隔
类型 体外DNA合成、体内DNA合成及其他
产品 DNA储存装置、DNA定序盒、DNA合成平台等。
服务 资料编码服务、资料搜寻服务、资料储存服务、咨询服务等。
科技 次世代定序、聚合酵素链锁反应(PCR)、CRISPR、DNA合成等。
成分 DNA链、储存媒体、编码软体、解码软体及其他组件。
目的 归檔、资料备份、资料復原、资料加密等等。
流程 资料编码、资料解码、资料储存、资料检索及其他相关任务。
实作方法 云端部署、本地部署、混合部署及其他
最终用户 生技公司、研究机构、政府机构、医疗保健提供者及其他
解决方案 整合系统、独立解决方案、客製化解决方案等等。

DNA资料储存系统市场主要按类型划分,其中合成DNA储存系统凭藉其高储存密度和耐久性占据主导。生物技术和製药等需要长期数据储存的行业需求是推动该细分市场成长的主要动力。数据复杂性的不断提高以及对安全归檔解决方案日益增长的需求正在推动该细分市场的成长,而合成技术的进步则进一步增强了其吸引力。

在技​​术领域,定序技术占据主导地位,它是读取和检索储存资料的关键。这个领域对于基因组学和个人化医疗等应用至关重要,因为在这些领域,精确的数据收集至关重要。定序速度和准确性的持续提升以及成本的降低是推动其成长要素,使其应用范围超越了传统的科研环境。

在应用领域,归檔储存细分市场处于领先地位,这主要得益于数位资料的爆炸性成长以及对永续储存解决方案的需求。媒体娱乐、政府和国防等关键产业正在采用DNA资料储存技术,因为它具有长期保存能力且占用空间小。数位化转型趋势以及对资料保存日益增长的重视,正在推动该细分市场的需求成长。

在终端用户中,科研机构占据主导地位。这些机构是创新储存技术的早期采用者。基因组研究和生物资讯学产生的大规模数据集需要高容量储存解决方案来管理,这推动了市场需求。学术界和产业界研究活动的持续拓展和合作预计将继续支撑这一领域的成长。

在组件板块中,「储存设备」子板块(包括DNA合成和定序设备)因其重要性而脱颖而出。这些元件是DNA资料储存系统运作的必要组成部分,其需求受到技术进步和高效资料管理解决方案需求的驱动。加大研发投入以及开发更具成本效益和可扩展性的储存设备是推动该板块成长的关键趋势。

区域概览

北美:北美DNA资料储存系统市场高度成熟,这主要得益于生物技术和资料密集型产业的巨额投资。美国处于领先地位,医疗、生命科学和IT产业的需求强劲。加拿大也透过专注于基因组数据储存的研究和开发,为市场成长做出了贡献。

欧洲:欧洲市场发展趋于中等成熟度,主要受医疗保健和製药业的强劲需求所驱动。英国和德国凭藉其先进的研发能力和政府对生物技术创新的支持,做出了显着贡献。该地区对资料隐私和安全的重视也进一步提升了市场渗透率。

亚太地区:在亚太地区,受生物技术和医疗保健基础设施投资不断增加的推动,DNA资料储存系统市场正快速成长。中国和日本是主要参与者,在基因组研究和资料储存技术领域取得了显着进展。该地区日益重视数位转型也促进了市场扩张。

拉丁美洲:拉丁美洲的DNA资料储存系统市场仍处于起步阶段,医疗和农业领域对其兴趣日益浓厚。巴西和墨西哥是生物技术研发领域的重要投资国。该地区对技术创新的日益重视预计将推动未来市场成长。

中东和非洲:中东和非洲市场尚处于起步阶段,需求主要由医疗和学术研究领域驱动。阿联酋和南非是主导的国家,大力投资基因组研究和资料储存解决方案。该地区对医疗保健系统现代化的重视也推动了市场发展。

主要趋势和驱动因素

趋势一:DNA合成技术的进步

由于DNA合成技术的显着进步,DNA资料储存市场正经历快速成长。这些创新降低了DNA链合成的成本和所需时间,使DNA储存成为大规模资料归檔更切实可行的选择。随着合成效率的提高,DNA作为一种长期、高密度储存介质的潜力越来越大,吸引了许多寻求以紧凑耐用格式储存海量资料的行业的关注。

趋势二:长期资料归檔的需求日益增长

包括医疗保健、金融和政府在内的各个行业对长期资料归檔解决方案的需求日益增长。 DNA资料储存具有独特的优势,能够将资讯保存数千年而不发生劣化。这一趋势的驱动力在于安全、永续储存海量资料的需求,而DNA解决方案在耐久性和稳定性方面超越了传统的磁性和光学储存技术。

三大关键趋势:与云端储存解决方案的集成

将DNA资料储存与云端解决方案结合正成为一大趋势,提供能够充分利用两种技术优势的混合储存模型。云端服务供应商正在考虑将DNA储存作为卸载「冷资料」(即存取频率低但出于合规或历史记录目的必须保留的资料)的手段。这种整合有望透过结合云端服务的扩充性和DNA储存的持久性来加强资料管理策略。

四大关键趋势:监管支持和标准化努力。

监管支援和标准化工作在DNA资料储存技术的推广应用中发挥着至关重要的作用。各国政府和国际组织已开始认识到DNA储存技术在资料保存方面的潜力,并正致力于制定相关标准,以确保互通性和可靠性。这些努力预计将为该技术的应用提供框架,并鼓励对研发进行投资,从而促进其在整个行业的广泛应用。

五大趋势:加大研发投入

由于DNA资料储存具有革新资料储存模式的巨大潜力,该市场正迎来研发投入的激增。公营和公共部门都在投入资源探索DNA作为储存介质的潜力,重点在于提升读写速度、纠错能力和可扩展性。这股投资热潮正在加速技术进步,为DNA储存在未来几年成为主流解决方案铺路。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制因素
  • 复合年均成长率:成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章:细分市场分析

  • 市场规模及预测:依类型
    • 体外DNA合成
    • 体内DNA合成
    • 其他的
  • 市场规模及预测:依产品划分
    • DNA储存装置
    • DNA定序盒
    • DNA合成平台
    • 其他的
  • 市场规模及预测:依服务划分
    • 资料编码服务
    • 数据采集服务
    • 资料储存服务
    • 咨询服务
    • 其他的
  • 市场规模及预测:依技术划分
    • 次世代定序
    • 聚合酵素链锁反应
    • CRISPR
    • DNA合成
    • 其他的
  • 市场规模及预测:依组件划分
    • DNA链
    • 储存媒体
    • 编码软体
    • 解码软体
    • 其他的
  • 市场规模及预测:依应用领域划分
    • 长期储存
    • 资料备份
    • 资料恢復
    • 资料加密
    • 其他的
  • 市场规模及预测:依市场细分
    • 基于云端的
    • 现场
    • 杂交种
    • 其他的
  • 市场规模及预测:依最终用户划分
    • 生技公司
    • 研究机构
    • 政府机构
    • 医疗保健提供者
    • 其他的
  • 市场规模及预测:依製程划分
    • 资料编码
    • 数据解码
    • 资料网关
    • 数据采集
    • 其他的
  • 市场规模及预测:按解决方案划分
    • 整合系统
    • 独立解决方案
    • 客製化解决方案
    • 其他的

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 供需差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 监管概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章:公司简介

  • Twist Bioscience
  • Microsoft
  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • DNA Script
  • Catalog Technologies
  • Quantum Corporation
  • Western Digital
  • Seagate Technology
  • IBM
  • Fujitsu
  • Hitachi
  • Helixworks Technologies
  • Zymergen
  • Ginkgo Bioworks
  • BASF
  • Merck KGaA
  • Oxford Nanopore Technologies
  • GenScript Biotech

第九章 关于我们

简介目录
Product Code: GIS10577

The global DNA Data Storage Systems Market is projected to grow from $1.2 billion in 2025 to $5.8 billion by 2035, at a compound annual growth rate (CAGR) of 16.5%. Growth is driven by increasing data generation, advancements in DNA synthesis and sequencing technologies, and the demand for long-term, high-density storage solutions. The DNA Data Storage Systems Market is characterized by its nascent yet rapidly evolving structure. Leading segments include synthesis-based storage solutions, which hold approximately 60% of the market share, followed by sequencing-based retrieval systems at 30%, and other ancillary technologies at 10%. Key applications are primarily in archival data storage, with emerging interest in healthcare and life sciences for long-term data preservation. The market is moderately consolidated, with a few key players dominating, but new entrants are increasing due to technological advancements. Volume insights are currently limited due to the early stage of commercialization, but installations are primarily concentrated in research institutions and pilot projects.

The competitive landscape is marked by the presence of both global technology giants and specialized regional players. The degree of innovation is high, driven by advancements in synthetic biology and nanotechnology. There is a noticeable trend in mergers and acquisitions, as larger firms acquire startups to bolster their technological capabilities. Strategic partnerships between technology companies and research institutions are also prevalent, aiming to accelerate development and commercialization of DNA data storage solutions.

Market Segmentation
TypeIn-vitro DNA Synthesis, In-vivo DNA Synthesis, Others
ProductDNA Storage Devices, DNA Sequencing Kits, DNA Synthesis Platforms, Others
ServicesData Encoding Services, Data Retrieval Services, Data Storage Services, Consulting Services, Others
TechnologyNext-Generation Sequencing, Polymerase Chain Reaction, CRISPR, DNA Synthesis, Others
ComponentDNA Strands, Storage Media, Encoding Software, Decoding Software, Others
ApplicationArchival Storage, Data Backup, Data Recovery, Data Encryption, Others
ProcessData Encoding, Data Decoding, Data Storage, Data Retrieval, Others
DeploymentCloud-Based, On-Premises, Hybrid, Others
End UserBiotechnology Companies, Research Institutions, Government Agencies, Healthcare Providers, Others
SolutionsIntegrated Systems, Standalone Solutions, Custom Solutions, Others

The DNA data storage systems market is primarily segmented by Type, with the Synthetic DNA segment leading due to its high storage density and durability. This segment is driven by industries such as biotechnology and pharmaceuticals, which require long-term data preservation. The increasing complexity of data and the need for secure archival solutions are propelling growth in this segment, with advancements in synthesis technologies further enhancing its appeal.

In the Technology segment, the Sequencing technology dominates, as it is crucial for reading and retrieving stored data. This segment is essential for applications in genomics and personalized medicine, where precise data retrieval is critical. The continuous improvements in sequencing speed and accuracy, along with cost reductions, are significant growth drivers, making it more accessible for broader applications beyond traditional research environments.

The Application segment sees the Archival Storage subsegment at the forefront, driven by the exponential growth of digital data and the need for sustainable storage solutions. Key industries such as media and entertainment, as well as government and defense, are adopting DNA data storage for its longevity and minimal physical footprint. The trend towards digital transformation and the increasing emphasis on data preservation are fueling demand in this segment.

Among End Users, the Research Laboratories segment is predominant, as these facilities are early adopters of innovative storage technologies. The demand is fueled by the need for high-capacity storage solutions to manage large datasets generated by genomic research and bioinformatics. The ongoing expansion of research activities and collaborations across academic and commercial sectors is expected to sustain growth in this segment.

The Component segment highlights the prominence of the Storage Device subsegment, which includes DNA synthesis and sequencing equipment. These components are vital for the operationalization of DNA data storage systems, with demand driven by technological advancements and the need for efficient data management solutions. The increasing investment in R&D and the development of more cost-effective and scalable storage devices are key trends supporting this segment's growth.

Geographical Overview

North America: The DNA data storage systems market in North America is highly mature, driven by significant investments in biotechnology and data-intensive sectors. The United States is at the forefront, with robust demand from healthcare, life sciences, and IT industries. Canada also contributes to market growth, focusing on research and development in genomic data storage.

Europe: Europe exhibits moderate market maturity with strong demand from the healthcare and pharmaceutical industries. The United Kingdom and Germany are notable contributors, leveraging advanced research capabilities and government support for biotechnology innovations. The region's focus on data privacy and security further propels market adoption.

Asia-Pacific: The Asia-Pacific region is experiencing rapid growth in the DNA data storage systems market, driven by increasing investments in biotechnology and healthcare infrastructure. China and Japan are key players, with significant advancements in genomic research and data storage technologies. The region's growing focus on digital transformation supports market expansion.

Latin America: The DNA data storage systems market in Latin America is in the nascent stage, with growing interest from the healthcare and agricultural sectors. Brazil and Mexico are notable countries, investing in biotechnology research and development. The region's increasing focus on technological innovation is expected to drive future market growth.

Middle East & Africa: The market in the Middle East & Africa is emerging, with demand primarily driven by healthcare and academic research sectors. The United Arab Emirates and South Africa are leading countries, investing in genomic research and data storage solutions. The region's emphasis on modernizing healthcare systems supports market development.

Key Trends and Drivers

Trend 1 Title: Advancements in DNA Synthesis Technologies

The DNA data storage market is experiencing rapid growth due to significant advancements in DNA synthesis technologies. These innovations are reducing the cost and time required to synthesize DNA strands, making DNA storage a more viable option for large-scale data archiving. As synthesis becomes more efficient, the potential for DNA to serve as a long-term, high-density storage medium increases, attracting interest from industries looking to preserve vast amounts of data in a compact and durable format.

Trend 2 Title: Growing Demand for Long-Term Data Archiving

There is an increasing demand for long-term data archiving solutions across various sectors, including healthcare, finance, and government. DNA data storage offers a unique advantage with its potential to preserve information for thousands of years without degradation. This trend is driven by the need to store ever-growing volumes of data securely and sustainably, with DNA providing a solution that surpasses traditional magnetic and optical storage technologies in longevity and stability.

Trend 3 Title: Integration with Cloud Storage Solutions

The integration of DNA data storage with cloud-based solutions is emerging as a key trend, offering hybrid storage models that leverage the strengths of both technologies. Cloud providers are exploring DNA storage as a means to offload cold data, which is infrequently accessed but must be retained for compliance or historical purposes. This integration is poised to enhance data management strategies by combining the scalability of cloud services with the permanence of DNA storage.

Trend 4 Title: Regulatory Support and Standardization Efforts

Regulatory support and standardization efforts are playing a crucial role in the adoption of DNA data storage technologies. Governments and international bodies are beginning to recognize the potential of DNA storage for data preservation, leading to the development of standards that ensure interoperability and reliability. These efforts are expected to facilitate broader industry adoption by providing a framework for implementation and encouraging investment in research and development.

Trend 5 Title: Increased Investment in Research and Development

The DNA data storage market is witnessing increased investment in research and development, driven by the potential to revolutionize data storage paradigms. Both private and public sectors are allocating resources to explore the capabilities of DNA as a storage medium, focusing on improving read/write speeds, error correction, and scalability. This influx of investment is accelerating technological advancements, paving the way for DNA storage to become a mainstream solution in the coming years.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Process
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 In-vitro DNA Synthesis
    • 4.1.2 In-vivo DNA Synthesis
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 DNA Storage Devices
    • 4.2.2 DNA Sequencing Kits
    • 4.2.3 DNA Synthesis Platforms
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Data Encoding Services
    • 4.3.2 Data Retrieval Services
    • 4.3.3 Data Storage Services
    • 4.3.4 Consulting Services
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Next-Generation Sequencing
    • 4.4.2 Polymerase Chain Reaction
    • 4.4.3 CRISPR
    • 4.4.4 DNA Synthesis
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 DNA Strands
    • 4.5.2 Storage Media
    • 4.5.3 Encoding Software
    • 4.5.4 Decoding Software
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Archival Storage
    • 4.6.2 Data Backup
    • 4.6.3 Data Recovery
    • 4.6.4 Data Encryption
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 Cloud-Based
    • 4.7.2 On-Premises
    • 4.7.3 Hybrid
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Biotechnology Companies
    • 4.8.2 Research Institutions
    • 4.8.3 Government Agencies
    • 4.8.4 Healthcare Providers
    • 4.8.5 Others
  • 4.9 Market Size & Forecast by Process (2020-2035)
    • 4.9.1 Data Encoding
    • 4.9.2 Data Decoding
    • 4.9.3 Data Storage
    • 4.9.4 Data Retrieval
    • 4.9.5 Others
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Integrated Systems
    • 4.10.2 Standalone Solutions
    • 4.10.3 Custom Solutions
    • 4.10.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Deployment
      • 5.2.1.8 End User
      • 5.2.1.9 Process
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Deployment
      • 5.2.2.8 End User
      • 5.2.2.9 Process
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Deployment
      • 5.2.3.8 End User
      • 5.2.3.9 Process
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Deployment
      • 5.3.1.8 End User
      • 5.3.1.9 Process
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Deployment
      • 5.3.2.8 End User
      • 5.3.2.9 Process
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Deployment
      • 5.3.3.8 End User
      • 5.3.3.9 Process
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Deployment
      • 5.4.1.8 End User
      • 5.4.1.9 Process
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Deployment
      • 5.4.2.8 End User
      • 5.4.2.9 Process
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Deployment
      • 5.4.3.8 End User
      • 5.4.3.9 Process
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Deployment
      • 5.4.4.8 End User
      • 5.4.4.9 Process
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Deployment
      • 5.4.5.8 End User
      • 5.4.5.9 Process
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Deployment
      • 5.4.6.8 End User
      • 5.4.6.9 Process
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Deployment
      • 5.4.7.8 End User
      • 5.4.7.9 Process
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Deployment
      • 5.5.1.8 End User
      • 5.5.1.9 Process
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Deployment
      • 5.5.2.8 End User
      • 5.5.2.9 Process
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Deployment
      • 5.5.3.8 End User
      • 5.5.3.9 Process
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Deployment
      • 5.5.4.8 End User
      • 5.5.4.9 Process
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Deployment
      • 5.5.5.8 End User
      • 5.5.5.9 Process
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Deployment
      • 5.5.6.8 End User
      • 5.5.6.9 Process
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Deployment
      • 5.6.1.8 End User
      • 5.6.1.9 Process
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Deployment
      • 5.6.2.8 End User
      • 5.6.2.9 Process
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Deployment
      • 5.6.3.8 End User
      • 5.6.3.9 Process
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Deployment
      • 5.6.4.8 End User
      • 5.6.4.9 Process
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Deployment
      • 5.6.5.8 End User
      • 5.6.5.9 Process
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Twist Bioscience
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Microsoft
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Illumina
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Thermo Fisher Scientific
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Agilent Technologies
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 DNA Script
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Catalog Technologies
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Quantum Corporation
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Western Digital
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Seagate Technology
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 IBM
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Fujitsu
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Hitachi
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Helixworks Technologies
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Zymergen
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Ginkgo Bioworks
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 BASF
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Merck KGaA
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Oxford Nanopore Technologies
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 GenScript Biotech
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us